Intravenous Drug Use and Hepatitis C Virus in Iran

AUTHORS

Mehdi Zobeiri 1 , * , Mehdi Zobeiri 1 , * , Peyman Adibi 2 , Peyman Adibi 2 , Seyed Moayed Alavian 3 , Seyed Moayed Alavian 3

1 Department of Internal Medicine, Kermanshah University of Medical Sciences, School of Medicine, Imam Reza Hospital, Kermanshah, IR Iran

2 Department of Gastroenterology, Isfahan University of Medical Sciences, Isfahan, IR Iran

3 Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran

Corresponding Authors:

How to Cite: Zobeiri M, Zobeiri M, Adibi P, Adibi P, Alavian S M, et al. Intravenous Drug Use and Hepatitis C Virus in Iran, Hepat Mon. Online ahead of Print ; 12(1):9-10. doi: 10.5812/kowsar.1735143X.797.

ARTICLE INFORMATION

Hepatitis Monthly: 12 (1); 9-10
Published Online: December 31, 2011
Article Type: Editorial
Received: December 7, 2011
Accepted: January 6, 2012
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

This article does not have abstract.

Keywords

Hepatitis C Hepatitis C Antibodies Association Non-Hodgkins Lymphoma

© 2011, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: